IRIS UniCatt

Laurenti, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.839
EU - Europa 9.353
AS - Asia 8.722
SA - Sud America 2.257
AF - Africa 256
OC - Oceania 182
Continente sconosciuto - Info sul continente non disponibili 15
Totale 32.624
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.481
SG - Singapore 4.111
DE - Germania 2.509
CN - Cina 2.378
BR - Brasile 1.863
SE - Svezia 1.729
IT - Italia 1.507
UA - Ucraina 694
FR - Francia 594
GB - Regno Unito 552
IE - Irlanda 533
VN - Vietnam 494
IN - India 419
ID - Indonesia 358
FI - Finlandia 279
RU - Federazione Russa 267
CA - Canada 203
AR - Argentina 166
AU - Australia 154
TR - Turchia 146
PL - Polonia 134
HK - Hong Kong 118
BD - Bangladesh 110
MX - Messico 105
JP - Giappone 89
NL - Olanda 86
KR - Corea 85
IQ - Iraq 77
AT - Austria 68
ZA - Sudafrica 62
ES - Italia 61
EC - Ecuador 52
BE - Belgio 45
CI - Costa d'Avorio 44
CO - Colombia 38
SA - Arabia Saudita 37
VE - Venezuela 35
PK - Pakistan 34
UZ - Uzbekistan 34
MA - Marocco 33
CH - Svizzera 32
CZ - Repubblica Ceca 32
EG - Egitto 32
PY - Paraguay 29
IR - Iran 28
NZ - Nuova Zelanda 28
HU - Ungheria 27
RO - Romania 27
CL - Cile 24
KE - Kenya 23
IL - Israele 22
LT - Lituania 21
NP - Nepal 19
PE - Perù 19
AE - Emirati Arabi Uniti 18
DZ - Algeria 18
JO - Giordania 18
PT - Portogallo 17
GR - Grecia 16
BG - Bulgaria 14
BO - Bolivia 14
UY - Uruguay 14
LB - Libano 13
TH - Thailandia 13
NO - Norvegia 12
LK - Sri Lanka 10
RS - Serbia 10
SK - Slovacchia (Repubblica Slovacca) 10
AZ - Azerbaigian 9
BA - Bosnia-Erzegovina 9
DO - Repubblica Dominicana 9
ET - Etiopia 9
HR - Croazia 9
OM - Oman 9
AL - Albania 8
KZ - Kazakistan 8
MD - Moldavia 8
MY - Malesia 8
PH - Filippine 8
JM - Giamaica 7
QA - Qatar 7
SI - Slovenia 7
SN - Senegal 7
TT - Trinidad e Tobago 7
EU - Europa 6
TN - Tunisia 6
BY - Bielorussia 5
BZ - Belize 5
DK - Danimarca 5
EE - Estonia 5
GE - Georgia 5
KG - Kirghizistan 5
LV - Lettonia 5
MK - Macedonia 5
PA - Panama 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AM - Armenia 4
AO - Angola 4
GA - Gabon 4
NI - Nicaragua 4
Totale 32.550
Salva come PNG Salva come JPEG
Città #
Singapore 1.756
Chandler 1.394
Ashburn 949
Beijing 544
Dublin 514
Jacksonville 421
San Mateo 355
Jakarta 319
Los Angeles 315
Dearborn 304
Nanjing 299
Wilmington 272
New York 253
Hefei 248
Milan 245
Ann Arbor 219
Rome 215
Boston 199
Munich 188
Hyderabad 178
Florence 174
Ho Chi Minh City 173
Cattolica 170
Dallas 169
Houston 149
Chicago 147
Woodbridge 146
Redwood City 140
Moscow 139
São Paulo 137
Frankfurt am Main 134
Lawrence 133
Seattle 131
Princeton 126
Buffalo 123
Nanchang 122
Nürnberg 121
Redmond 111
Hanoi 109
Hong Kong 109
Lancaster 107
Marseille 104
Fairfield 96
Warsaw 88
Izmir 82
Kunming 80
Bremen 78
Seoul 74
Boardman 72
Rio de Janeiro 66
Kent 61
Brooklyn 60
Helsinki 60
Tokyo 60
Tianjin 59
London 57
Mountain View 56
Shenyang 54
Phoenix 52
Santa Clara 50
Norwalk 48
Washington 47
Abidjan 44
San Francisco 44
Zhengzhou 44
Atlanta 43
Belo Horizonte 43
Brussels 41
Düsseldorf 41
Guangzhou 40
Nuremberg 40
Cambridge 38
Hebei 38
Porto Alegre 38
Pune 38
Toronto 37
Sydney 36
Turku 36
Hangzhou 35
Jiaxing 35
Philadelphia 35
Vienna 35
Lappeenranta 34
Stockholm 34
The Dalles 33
Changsha 31
Tashkent 31
Auburn Hills 30
Montreal 30
Mexico City 29
Shanghai 29
Denver 28
Dhaka 28
Johannesburg 27
Melbourne 27
Minneapolis 27
Portland 27
Campinas 26
Curitiba 26
Detroit 26
Totale 14.765
Salva come PNG Salva come JPEG
Nome #
VITAMIN B12 DEFICIENCY: CORRELATION BETWEEN MTHFR POLYMORPHISMS AND CLINICAL AND LABORATORY FINDINGS 2.876
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation 641
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 400
Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis 348
Factors associated with mortality in bacteremic patients with hematologic malignancies. 342
Elevated lactate dehydrogenase has prognostic relevance in treatment-naïve patients affected by chronic lymphocytic leukemia with trisomy 12 315
Factors associated with mortality in bacteremic patients with hematologic malignancies. 203
Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease. 199
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 191
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 191
Correlation between paraproteinaemia and viral reactivation after allo-SCT 182
Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: safety and efficacy evaluation 180
Evaluation of intraorbital injection of rituximab for treatment of primary ocular adnexal lymphoma. A pilot study. 177
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 173
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments 165
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 164
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 161
Low-dose valganciclovir as preemptive therapy for cytomegalovirus infection occurring in allogeneic stem cell transplant recipients 158
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 158
Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia 154
Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: Safety and efficacy evaluation. 151
New and old monoclonal antibodies for the treatment of chronic lymphocytic leukemia 150
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab. 149
Role of (18)F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients 147
The use of low-dose alemtuzumab in pretreated B-cell chronic lymphocytic leukemia. Leukemia. 146
Low incidence of secondary neoplasia after autotransplantation for lymphoproliferative disease: the role of pre-transplant therapy 146
Work related acute leukemia and mucor mycosis in a boat-builder 144
Role of 18F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients. 143
All-trans retinoic acid in association with low dose cytosine arabinoside in the treatment of acute myeoid leukemia in elderly patients 143
Clinical and pathological heterogeneity in a series of 31 patients with IgM-related neuropathy 141
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication 141
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 140
EXTREME THROMBOCYTOSIS IN CHRONIC MYELOID LEUKEMIA IN THE ERA OF TYROSINE KINASE INHIBITORS 140
Role of microRNAs in Chronic Lymphocytic Leukemia 139
Hyperleukocytosis and leukostasis: management of a medical emergency 138
Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration 137
AB0 type does not affect platelet engraftment after autologous peripheral blood stem cell transplant in a series of 249 hematologic patients 137
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication. 137
H1N1 Influenza among Hematological Patients: Monocentric Influenza Cases from 2011 to 2016 136
Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia 134
Neurologic improvement after peripheral blood stem cell transplantation in poems 133
revalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience. 133
Usefulness of F-18 FDG PET/CT in the follow-up of POEMS syndrome after autologous peripheral blood stem cell transplantation 132
Hyperleukocytosis and leukostasis: management of a medical emergency 132
Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: Correlation with biologically-based risk stratification 132
Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs 132
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue 131
Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases 129
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia 128
TTR-related amyloid neuropathy: clinical, electrophysiological and pathological findings in 15 unrelated patients 128
Guillain-Barre' syndrome following Varicella zoster reactivation in Chronic Lymphocytic Leukemia treated with fludarabine 127
Light chain deposition in peripheral nerve as a cause of mononeuritis multiplex in Waldenström's macroglobulinaemia. 126
Granulocyte transfusions as adjunctive treatment of invasive fungal diseases in neutropenic patients 126
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 125
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 123
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 123
Chlorambucil plus Rituximab as Front-Line Therapy in Elderly/Unfit Patients Affected by B-Cell Chronic Lymphocytic Leukemia: Results of a Single-Centre Experience 122
Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience 121
Evaluation of intraorbital injection of rituximab for treatment of primary ocular adnexal lymphoma: a pilot study 121
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 121
Long-term follow up of frontline therapy with fludarabine and cyclophosphamide in chronic lymphocytic leukemia: impact of biological parameters on clinical outcome 120
Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome 119
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 119
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 118
Mycosis fungoides as a cause of severe obstructive sleep apnea 118
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 118
The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: a retrospective multicentric GIMEMA experience 117
High-dose glucocorticoids plus Ofatumumab in fludarabine/alemtuzumab-resistant B-cell chronic lymphocytic leukemia 117
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 117
The cumulative amount of serum-free light chain is a strong prognosticator in chronic lymphocytic leukemia 115
Chronic Lymphocytic Leukaemia: Census of Patients Treated in Italian Haematology Units 114
Non-tunnelled central venous catheters in adult stem cell transplantation recipients: an effective option 112
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 111
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia 111
Transcription factors implicated in late megakaryopoiesis as markers of outcome after azacitidine and allogeneic stem cell transplantation in myelodysplastic syndrome 110
B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: the growing saga of the IGHV3 subgroup gene usage 109
B-cell receptor configuration and adverse cytogenetics are associated with autoimmune hemolytic anemia in chronic lymphocytic leukemia 109
Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia. 109
Long-term outcomes of primary ocular adnexal lymphoma treatment with intraorbital rituximab injections. 108
Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease 107
Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid 106
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 106
Characterization and prognostic relevance of circulating microvesicles in chronic lymphocytic leukemia 105
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 105
Diagnostic framing of IgM monoclonal gammopathy: Focus on Waldenström macroglobulinemia 105
Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study 105
Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma 104
Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia 103
Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: correlation with biologically-based risk stratification. 103
Adverse drug reactions after intravenous rituximab infusion are more common in hematologic malignancies than in autoimmune disorders and can be predicted by the combination of few clinical and laboratory parameters: results from a retrospective, multicenter study of 374 patients 103
Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study 103
Unrelated cord blood transplantation and post-transplant cyclophosphamide 103
Regulatory T-cell number is increased in chronic lymphocytic leukemia patients and correlates with progressive disease 102
Allogeneic hematopoietic stem cell transplantation in therapy-related myeloid neoplasms (t-MN) of the adult: Monocentric observational study and review of the literature 101
Prognostic impact and risk factors of infections in patients with chronic lymphocytic leukemia treated with ibrutinib 101
Subcutaneous immunoglobulins in chronic lymphocytic leukemia with secondary antibody deficiency. A monocentric experience during Covid-19 pandemics 100
Unselected donor-derived hematopoietic stem cells boost for Chimeric Antigen Receptor T-cell associated hematotoxicity 99
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 99
the concomitance of lymphoma and breast carcinoma in the bone 99
Appropriate use of bendamustine in first-line therapy of chronic lymphocytic leukemia. Recommendations from SIE, SIES, GITMO Group 98
Totale 17.090
Salva come PNG Salva come JPEG
Categoria #
all - tutte 144.011
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 144.011
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021916 0 0 0 0 0 115 146 38 194 65 317 41
2021/20222.251 184 131 127 152 167 65 38 321 106 126 427 407
2022/20234.402 628 625 350 539 332 552 196 305 500 85 212 78
2023/20244.020 126 725 199 775 221 499 193 110 131 231 384 426
2024/20256.361 377 275 505 244 483 201 191 300 821 701 1.307 956
2025/20267.819 2.219 509 1.015 1.629 2.287 160 0 0 0 0 0 0
Totale 33.041